Reviewer
Shweta Sharma
  • Research scientist, UCSD
Research focus
  • Cancer biology
  • Cancer therapeutics, drug delivery, 3D culture and stem cell biology

Education

PhD

Publications

1. Shweta Sharma, Venkata R Kotamraju, Tarmo Molder, Tambet Teesalu, Erkki Ruoslahti. Tumor-penetrating nanosystem strongly suppresses breast tumor growth. Nano lett. 2017;17 (3), pp 1356-1364. Impact Factor: 13.77
2. Shweta Sharma, Aman Mann, Tarmo Molder, Venkata R Kotamraju, Tambet Teesalu, Erkki Ruoslahti. Vascular changes in tumors resistant to a vascular disrupting nanoparticle treatment. Journal of Controlled Release 2017; (268) pp 49-56. Impact Factor: 7.70
3. Hedi Hunt, Lorena Simón-Gracia, Allan Tobi, Venkata Ramana Kotamraju, Shweta Sharma, Mait Nigul, Kazuki N Sugahara, Erkki Ruoslahti. Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles. Journal of Controlled Release 2017; 8 (260), pp 142-153. Impact Factor: 7.70
4. Lauri Paasonen, Shweta Sharma, Gary B Braun, Venkata R Kotamraju, Zhigang She, Kazuki N Sugahara, Marjo Yliperttula, Bainan Wu, Maurizio Pellecchia, Erkki Ruoslahti, Tambet Teesalu. New p32/gC1qR ligands for targeted tumor drug delivery. ChemBioChem 2016 (17), pp. 570-575. Impact Factor: 3.1
5. Shweta Sharma. Promise of newborn stem cells to revolutionize clinical practice. Technology Network 2015. (http://www.technologynetworks.com/StemCells/news.aspx?id=185211)
★Invited article by Cord Blood Registry (CBR), San Bruno, CA, USA.
6. Venkata R Kotamraju, Shweta Sharma, Poornima Kolhar, Lilach Agemy, James Pavlovich, Erkki Ruoslahti. Increasing tumor accessibility with conjugatable disulfide bridged tumor-penetrating peptides for cancer diagnosis and treatment. Breast Cancer: Basic and Clinical Research 2016;9 (Suppl 2), pp 79-87.
7. Amanda M Hamilton, Sallouha A Ahmed, Shweta Sharma, Venkata R Kotamraju, Paula J Foster, Kazuki N Sugahara, Erkki Ruoslahti, Brian K Rutt. Nanoparticles coated with the tumor-penetrating peptide iRGD inhibit experimental breast cancer metastasis to the brain. Journal of Mol Med (Berl). 2015; 93(9): 991-1001. Impact Factor: 5.1
8. Shweta Sharma, Deepika Gupta, Sujata Mohanty, Manjeet Jassal, Ashwini K Agarwal, Radhika Tandon. Surface modified electrospun Poly-caprolactone scaffold with improved optical transparency and bioactivity for damaged ocular surface reconstruction. Invest Ophthalmol Vis Sci. (IOVS) 2014; 55 (2): 899-907. Impact Factor: 3.3
9. Lilach Agemy, Venkata R Kotamraju, Dinorah F Morvinski, Shweta Sharma, Kazuki N Sugahara, Erkki Ruoslahti. Proapoptotic Peptide-Mediated Cancer Therapy to Cell Surface p32. Molecular Therapy 2013; 21 (12): 2195-2204. Impact Factor: 6.93
★Featured cover illustration.
10. Shweta Sharma, Murugesan Vanathi, Sujata Mohanty, Radhika Tandon. Limbal Epithelial Stem Cells in Corneal Regeneration. Delhi Journal of Ophthalmology 2013;24(1):43-50.
★Invited review article
11. Shweta Sharma, Radhika Tandon, Seema Kashyap, Sujata Mohanty, Murugesan Vanathi. Reconstruction of Severely Damaged Ocular Surface using Autologous Cultivated Limbal Stem Cell Transplantation followed by Sequential DALK Surgery. Ophthalmic Research 2013;50:59-64. Impact Factor: 1.34
12. Shweta Sharma, Sujata Mohanty, Deepika Gupta, Manjeet Jassal, Ashwini K Agarwal, Radhika Tandon. Cellular response of limbal epithelial cells on electrospun poly-ε-caprolactone nanofibrous scaffolds for ocular surface bioengineering: a preliminary in vitro study. Molecular Vision 2011; 17:2898-2910. Impact Factor: 2.24
13. Sudip Sen, Shweta Sharma, Anand Gupta, Noopur Gupta, Himi Singh, Ajoy Roychaudhury, Sujata Mohanty, Seema Sen, Tapas C Nag, Radhika Tandon. Molecular characterization of oral mucosal epithelial cells as an ideal autograft in bilateral ocular surface disease. Invest Ophthalmol Vis Sci. (IOVS) 2011; 20; 52(13):9548-9554. Impact Factor: 3.3
14. Shweta Sharma, Sujata Mohanty, Radhika Tandon, Namrata Sharma, Murugesan Vanathi, Seema Sen, Seema Kashyap, Neeta Singh. Culture of Corneal Limbal Epithelial Stem Cells: Experience from Benchtop to Bedside in a Tertiary Care Hospital in India. Cornea 2011 Nov; 30(11):1223-32. Impact Factor: 1.83
您可以切换至中文站点,以获得适用于中国用户的内容 中文站点
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.